PM Society Advertising awards finalists announced
pharmafile | January 9, 2014 | News story | Medical Communications, Sales and Marketing |Â Â London, advertising, pm awardsÂ
The finalists for the 2013 PM Society Advertising awards have been announced today as pharma and their med comms agencies gear up to see who was the best of the best in 2013.
This year 28 agencies and 37 pharma companies are represented on the shortlist as entrants for the awards.
The ceremony aims to recognise the best in pharma advertising and marketing innovation, whilst highlighting the most creative and effective work across the industry.
The event will take place on Friday 31 January at the Grosvenor House Hotel in central London.
The agency finalists are:
- Bedgebury Communications
- Cherry
- Concentric Advertising London
- Dice Medical Communications
- emotive
- Frontera London
- Halesway
- Hanson Zandi Advertising
- Havas Life Medicom
- HAVAS LYNX
- HUG Advertising
- ICC Lowe London
- Langland
- McCann Health
- McCann Manchester
- MEDIKIDZ
- nitrogen
- Ogilvy DigitalHealth
- Ogilvy Healthworld UK
- OPEN LEC
- PAN
- Real Science Communications
- Saatchi & Saatchi Health
- Swordfish Advertising
- VCCP Health
- Woolley Pau Gyro
- Woolley Pau Gyro/Breakfast of Champions
- WRG Creative Communication
Advertising and market access debate
For the first time, the PM Society will also be holding an educational event as a precursor to the awards ceremony.
‘Industry and the NHS: can promotion and partnership co-exist?’ will provide a forum for debate on the role marketing and advertising can play in the context of UK market access. The discussion will begin at 10am on 31 January, several hours before the main awards ceremony.
Speakers include Di Vegh, NHS partnership manager at the ABPI; Felicity Greene, director of operations at NHS South Commissioning Support Unit and Jonathan Dancer of Redbow Consulting Group.
This debate will be chaired by the PM Society vice-chair and market access interest group lead Dr Beverly Barr. Question and answer sessions will also follow, allowing attendees to participate.
Related Content
Ambitious plans for leading cancer research centre announced
Aviva Capital Partners (ACP), an infrastructure and real estate investor, and Socius, a mixed-use developer, …
Touchlight completes expansion of one of world’s largest DNA manufacturing facilities in London
Touchlight, a company that focuses on pioneering enzymatic DNA production, has announced that it has …
MSD unveils plans for $1.3bn central London research centre
MSD has lifted the lid on plans to build a $1.3 billion research centre in …
